EXPRESSION-ENHANCED POLYPEPTIDES
    2.
    发明申请
    EXPRESSION-ENHANCED POLYPEPTIDES 有权
    表达增强多糖

    公开(公告)号:US20090053223A1

    公开(公告)日:2009-02-26

    申请号:US11572116

    申请日:2005-07-15

    摘要: A composite polypeptide, said composite polypeptide comprising a desired polypeptide and an expression enhancing domain (“EED”), said EED comprising first and second cysteine amino acid residues Cys1 and Cys2, respectively, Cys1 being located closer to the N-terminus of the composite polypeptide molecule than Cys2, wherein Cys1 and Cys2 are separated by a polypeptide linker, said linker—being free of cysteine and proline;—defining a length sufficient to allow Cys1 and Cys2 to engage in an intramolecular disulfide bond with one another; and—having a flexible polypeptide conformation essentially free of secondary polypeptide structure in aqueous solution, wherein at least one of Cys1 and Cys2 is derivatized with a derivatization moiety.

    摘要翻译: 复合多肽,所述复合多肽包含期望的多肽和表达增强结构域(“EED”),所述EED分别包含第一和第二半胱氨酸氨基酸残基Cys1和Cys2,Cys1位于更靠近复合物的N末端 多肽分子,其中Cys1和Cys2被多肽接头分离,所述连接体不含半胱氨酸和脯氨酸; - 限定足以允许Cys1和Cys2彼此参与分子内二硫键的长度; 并且具有在水溶液中基本上不含次级多肽结构的柔性多肽构象,其中Cys1和Cys2中的至少一个被衍生化部分衍生化。

    Expression-enhanced polypeptides
    5.
    发明授权
    Expression-enhanced polypeptides 有权
    表达增强多肽

    公开(公告)号:US08518403B2

    公开(公告)日:2013-08-27

    申请号:US11572116

    申请日:2005-07-15

    摘要: A composite polypeptide, said composite polypeptide comprising a desired polypeptide and an expression enhancing domain (“EED”), said EED comprising first and second cysteine amino acid residues Cys1 and Cys2, respectively, Cys1 being located closer to the N-terminus of the composite polypeptide molecule than Cys2, wherein Cys1 and Cys2 are separated by a polypeptide linker, said linker—being free of cysteine and proline;—defining a length sufficient to allow Cys1 and Cys2 to engage in an intramolecular disulfide bond with one another; and—having a flexible polypeptide conformation essentially free of secondary polypeptide structure in aqueous solution, wherein at least one of Cys1 and Cys2 is derivatized with a derivatization moiety.

    摘要翻译: 复合多肽,所述复合多肽包含期望的多肽和表达增强结构域(“EED”),所述EED分别包含第一和第二半胱氨酸氨基酸残基Cys1和Cys2,Cys1位于更靠近复合物的N末端 多肽分子,其中Cys1和Cys2被多肽接头分离,所述连接体不含半胱氨酸和脯氨酸; - 限定足以允许Cys1和Cys2彼此参与分子内二硫键的长度; 并且具有在水溶液中基本上不含次级多肽结构的柔性多肽构象,其中Cys1和Cys2中的至少一个被衍生化部分衍生化。